Consolidated Balance Sheet - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Cash and cash equivalents:
Noninterest-bearing	$ 23,933	$ 30,284
Interest-bearing	10,358	11,918
Total cash and cash equivalents	34,291	42,202
Interest bearing time deposits with other banks	3,820	3,820
Equity securities	1,815	1,747
Available-for-sale securities	444,741	425,912
Loans held for sale	9,393	9,607
Loans (net of allowance for credit losses: $ 2025, 22,806; 2024, $21,699)	2,327,816	2,291,543
Premises and equipment	20,998	21,395
Accrued interest receivable	10,698	10,307
Goodwill	85,758	85,758
Bank owned life insurance	51,501	50,341
Other intangibles	2,221	2,892
Fair value of derivative instruments - asset	6,927	10,370
Deferred tax asset	11,440	15,199
Other assets	53,145	54,631
TOTAL ASSETS	3,064,564	3,025,724
Deposits:
Noninterest-bearing	516,657	532,776
Interest-bearing	1,860,322	1,849,252
Total deposits	2,376,979	2,382,028
Borrowed funds	309,448	297,721
Accrued interest payable	3,130	4,693
Fair value of derivative instruments - liability	4,100	5,817
Other liabilities	32,856	35,731
TOTAL LIABILITIES	2,726,513	2,725,990
STOCKHOLDERS’ EQUITY:
Preferred Stock $1.00 par value; authorized 3,000,000 shares 2025 and 2024; none issued in 2025 or 2024	0	0
Common Stock $1.00 par value; authorized 25,000,000 shares 2025 and 2024; issued 5,255,807 and 5,207,577 share in 2025 and 2024, respectively	5,256	5,208
Additional paid-in capital	147,965	144,984
Retained earnings	213,623	189,443
Accumulated other comprehensive loss	(12,377)	(23,521)
Treasury stock, at cost: 448,727 and 447,965 shares for 2025 and 2024, respectively	(16,416)	(16,380)
TOTAL STOCKHOLDERS’ EQUITY	338,051	299,734
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	$ 3,064,564	$ 3,025,724